INTERNATIONAL PATENT: ABBVIE INC. FILES APPLICATION FOR "CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED DRYING PROCESSES"

GENEVA, July 30 -- ABBVIE INC. (1 North Waukegan RoadNorth Chicago, IL 60064) filed a patent application (PCT/US2025/012025) for " CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED DRYING PROCESSES" on Jan 17, 2025. With publication no. WO/2025/155814, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHALAEV, Evgenyi (33776 Bridgehampton DriveDana Point, CA 92629), ABIAD, Maurice (5918 Bixby Village Drive, #111Long Beach, CA 90803)

Abstract: Provided herein are solid compositions comprising Clostrid...